The maximum efficiency increase in this simulation from fixed allocation to short-term trading can be observed to be up to 11.8 percentage points at an overall demand of 100 resources in this scenario.
With the increase in the size of the GNCs, the maximum extinction efficiency increased, and the maximum extinction position became red shifted [11, 16, 50 52].
Comparing the PX-3A in operation at Thot=1173 K with the one proposed here, the maximum electrical power output and the maximum cell conversion efficiency increased by 43 and 44%, respectively.
The maximum EQE and current efficiency increased from 3.9%% and 14.2 cd/A to 6.7 % and 22.4 cd/A, corresponding to improvements of 71 and 57 %, respectively, as compared with that of device without Au NPs.
Exergetic efficiency increased relatively to maximum 3% within this temperature limit.
Moreover, a gradual increase in the foam porosity at fixed PPI (pores per inch) value made the separation efficiency increased to a maximum value, then fall to a lower level, while by decreasing the PPI value of the foam at fixed porosity, the separation efficiency increased.
Beyond this exposure level, the thrombolysis efficiency increased to achieve a maximum value of 95±8%8% for a power of 200 W.
We demonstrate in an in vitro system that the thrombolytic speed associated with this proposed treatment can be almost doubled and reach its maximum efficiency without increasing the t-PA dose.
In addition, it is illustrated that the maximum efficiency point increases with increasing the incident light concentration in the radiative limit.
For all the inhibitors, the inhibition efficiency increased with increasing concentration, reaching a maximum at the highest tested concentration.
Inhibition efficiency increased with increasing the concentration of extract and maximum inhibition efficiency observed is 82.24 and 82.45% from EIS and PDP studies, respectively, at higher concentration.
